Delivery Order SPE2DB20D3101-SPE2DB25FRWL3
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Lisdexamfetamine 20 mg capsules (90-count units) with a ceiling value of $11,578.87. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a non-competitive set-aside arrangement and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract falls under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lisdexamfetamine 50 mg capsules (90-count units) under a firm fixed-price contract with a ceiling value of $1,633.75. The award was made on September 23, 2025, with an ultimate completion date of September 24, 2025. This delivery order represents a non-set-aside, competitively awarded procurement and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Lisdexamfetamine 50 mg capsules (100-count units) valued at $5,911.56. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is scheduled for ultimate completion by September 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 30 mg capsules (100-count units) on September 3, 2025, with a ceiling value of $1,176.88 and ultimate completion date of September 4, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under a larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Lisdexamfetamine 40 mg capsules (100-count units) under a firm fixed-price contract with a ceiling value of $1,137.22. This non-set-aside delivery order is scheduled for ultimate completion on August 19, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 40 mg capsules (100 count) valued at $1,289.97 under a firm fixed-price contract type. The award was made on June 17, 2025, with an ultimate completion date of June 18, 2025, and represents a non-set-aside competitive award. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a $10,066.22 delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lisdexamfetamine 20 mg capsules (90-count units). This is a firm fixed-price delivery order with an ultimate completion date of September 19, 2025, and represents a non-competitive set-aside contract. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $2,557.61 delivery order to AmerisourceBergen Drug Corp for Lisdexamfetamine 20 mg capsules (100 count) on September 25, 2025, with an ultimate completion date of September 26, 2025. This non-set-aside, firm fixed price delivery order was issued under a competitively awarded contract vehicle and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Lisdexamfetamine is a central nervous system stimulant medication...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for lisdexamfetamine 30 mg capsules (100-count units) with a ceiling value of $1,042.75. The contract, awarded on September 16, 2025, utilizes a firm fixed-price delivery order model with an ultimate completion date of September 17, 2025. This award represents a competitively awarded, non-set-aside transaction supporting federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 20 mg, with a contract ceiling value of $1,980.00 and an ultimate completion date of September 15, 2025. This competitively awarded, firm fixed-price delivery order was issued on September 12, 2025, with no set-aside designation. The product will be delivered to the contractor's facility in Conshohocken, Pennsylvania. This award is a child order under AmerisourceBergen Drug...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRWL3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 90 capsules of Lisdexamfetamine 30 mg with a ceiling value of $6,168.90. The contract, which was competitively awarded without a set-aside designation, carries a firm fixed price structure and was finalized on September 25, 2025, with an ultimate completion date of September 26, 2025. Performance will be executed at the vendor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen Drug Corp supplies a comprehensive range of medications and medical commodities to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The Lisdexamfetamine delivery supports the Defense Health Agency's pharmaceutical supply requirements, with the medication used for attention deficit hyperactivity disorder treatment in military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.2k | 9/25/25 |